Dr Alister
banner
dralister.bsky.social
Dr Alister
@dralister.bsky.social
Former academic now non clinical safety at Nxera Pharma. Twitter refugee. Loves Pharmacology, calcio and Italy. Happy to help anyone exit academia. #biosky
Mine too. We used to belive santacruz had one just one donkey that all the Abs we raised in together
December 30, 2024 at 8:40 AM
Is it just me or it feels like #scitwitter has now become #bluesci 😀
#FluorescenceFriday reminder that if you sprinkle turmeric into alcohol while shining a UV light on it, you get a brilliant fireworks display in a glass 🎇

#ChemSky 🧪
November 15, 2024 at 10:10 AM
Can I get Christmas lights made to look like this?
November 15, 2024 at 10:07 AM
Well after 3 years of commuting from Manchester to Reading and then to Cambridge (after a career change). I have moved back to the south, St Albans. Pandemic made us make some strange decisions!
September 17, 2024 at 7:38 PM
Charlie the kleptocat paysy friends a visit
September 7, 2024 at 8:26 PM
This thread, the comments and the article. Chefs kiss. And also i feel seen....
During the last six months there’s been a substantial increase in academics approaching me to ask about leaving #academia

This article articulates many of the reasons why they’re doing that…
"It is impossible to be a top-line manager and administrator and mentor and researcher and writer and outreach officer and IT expert and online instructor and pedagogical innovator and recruiter and teacher and marker and external examiner and press pundit and grant bidder and editor."
September 5, 2024 at 6:38 AM
neurocrine.gcs-web.com/news-release...

Topline results from our partners at Neurocrine - first of our extensive muscarinic portfolio assets developed by Nxera and our NxWave platform bring on phase 3!
Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1117568 in Adults with Schizophrenia | Neurocrine Biosciences
The Investor Relations website contains information about Neurocrine Biosciences's business for stockholders, potential investors, and financial analysts.
neurocrine.gcs-web.com
August 29, 2024 at 9:56 PM
images.app.goo.gl/h2Zem8cQHqKH... I think this reminds of the hype cycle we will get there but perhaps the initial expectation needs the reality check.
August 28, 2024 at 7:29 PM
Nice article covering drug discovery safety and target validation process, my soft spot for ion channels, as well as bringing in the human and societal aspects of a new mechanism of pain relief www.scientificamerican.com/article/new-...
New Pain Medication Suzetrigine Prevents Pain Signals from Reaching Brain
The medication initially known as VX-548 blocks sodium channels in nerves, blocking pain signals before they reach the brain
www.scientificamerican.com
August 26, 2024 at 10:11 AM
Hello blue sky who do i need to follow around here? Looking for fellow #scitwitter refugees
August 10, 2024 at 3:36 PM